MYELODYSPLASTIC SYNDROME WITH SINGLE LINEAGE DYSPLASIA

MYELODYSPLASTIC SYNDROME WITH SINGLE LINEAGE DYSPLASIA was reported 54 times

MYELODYSPLASTIC SYNDROME WITH SINGLE LINEAGE DYSPLASIA is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 10 0.0004
1 Poly(ADP-Ribose) Polymerase Inhibitor [EPC] 2 0.0001
2 Hydrolytic Lysosomal Glycosaminoglycan-specific Enzyme [EPC] 1 0.0001
3 Topoisomerase Inhibitor [EPC] 4 0.0001
4 Gonadotropin Releasing Hormone Receptor Antagonist [EPC] 1 0.0000
5 Erythropoiesis-stimulating Agent [EPC] 2 0.0000
6 Provitamin D2 Compound [EPC] 1 0.0000
7 Purine Antimetabolite [EPC] 3 0.0000
8 Complement Inhibitor [EPC] 1 0.0000
9 BCL-2 Inhibitor [EPC] 1 0.0000
10 Nitroimidazole Antimicrobial [EPC] 1 0.0000
11 Platinum-based Drug [EPC] 4 0.0000
12 Corticosteroid [EPC] 18 0.0000
13 CD20-directed Cytolytic Antibody [EPC] 4 0.0000
14 Folate Analog Metabolic Inhibitor [EPC] 5 0.0000
15 Nucleoside Metabolic Inhibitor [EPC] 3 0.0000
16 Interleukin-23 Antagonist [EPC] 1 0.0000
17 Kinase Inhibitor [EPC] 5 0.0000
18 alpha-Adrenergic Blocker [EPC] 1 0.0000
19 Leukocyte Growth Factor [EPC] 1 0.0000
20 Janus Kinase Inhibitor [EPC] 1 0.0000
21 Vitamin B12 [EPC] 2 0.0000
22 Microtubule Inhibitor [EPC] 1 0.0000
23 Loop Diuretic [EPC] 2 0.0000
24 Opioid Agonist [EPC] 1 0.0000
25 Platelet Aggregation Inhibitor [EPC] 2 0.0000
26 Vitamin D [EPC] 1 0.0000
27 beta-Adrenergic Blocker [EPC] 1 0.0000
28 Vitamin C [EPC] 1 0.0000
29 Nonsteroidal Anti-inflammatory Drug [EPC] 3 0.0000
30 Tumor Necrosis Factor Blocker [EPC] 2 0.0000